LivaNova PLC (LIVN)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

20 EASTBOURNE TERRACE LONDON, UNITED KINGDOM W2 6LG

LivaNova PLC operates as a medical technology company. The Company focuses on neuromodulation, cardiac surgery and cardiac rhythm management. LivaNova also develops medical solutions for the treatment of cardiovascular diseases.

Data based on most recent fiscal year report
Market Cap4.155 Billion Shares Outstanding48.21 Million Avg Volume621.339 Thousand
1-Yr BETA vs S&P TR1.16 Current Ratio2.14 Quick Ratio1.79
View SEC Filings from LIVN instead.
Q2 2019 All Institutions Hedge Funds 1
To trade LIVN now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 207 28 (2.89%)
Aggregate 13F shares on 06/30/2019: 42.556 Million 5.506 Million
Aggregate 13F shares on 03/31/2019: 41.604 Million 4.994 Million
Percent change: 2.29% 10.26%
Funds creating new positions: 28 9
Funds Adding to an existing position: 81 9
Funds closing out their position: 41 11
Funds reducing their position: 74 7
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding LIVN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

11.5 Thousand total shares from 5 transactions

Exercise Derivative Conversion (M)

605 total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MOORE DANIEL JEFFREY

  • Director
35,438 2019-08-19 12

HUSTON THAD ALLEN CHIEF FINANCIAL OFFICER

  • Officer
16,169 2019-08-12 7

MANKO DOUGLAS JOHN CHIEF ACCOUNTING OFFICER

  • Officer
2,352 2019-08-05 5

MCDONALD DAMIEN CEO

  • Officer
61,774 2019-08-01 8

RICHEY ROBERT JASON PRESIDENT

  • Officer
129,576 2019-07-08 0

ANDRLE EDWARD GENERAL MANAGER, NM

  • Officer
34,784 2019-06-28 7

SKEFFINGTON KEYNA PIDCOCK GENERAL COUNSEL

  • Officer
1,481 2019-06-28 5

BIANCHI FRANCESCO

  • Director
0 2019-06-18 3

NOVAK ALFRED J

  • Director
0 2019-06-18 5

MORRISON HUGH M

  • Director
0 2019-06-18 4

O'KANE SHARON

  • Director
0 2019-06-18 3

ROSENTHAL ARTHUR L

  • Director
0 2019-06-18 3

SAIA ANDREA LYNN

  • Director
0 2019-06-18 3

KOZY WILLIAM A

  • Director
0 2019-06-18 4

ENXING SENG STACY

  • Director
0 2019-06-18 2

HEBBELINCK TRUI CHIEF HUMAN RESOURCES OFFICER

  • Officer
0 2019-05-07 2

SIMPSON ALISTAIR GENERAL MANAGER, CS

  • Officer
1,945 2019-05-05 6

SEHGAL VIVID CHIEF FINANCIAL OFFICER

  • Officer
5,925 2019-02-28 0

WISE DAVID S CHIEF ADMINISTRATIVE OFFICER

  • Officer
27,929 2019-01-15 5

GIANOTTI STEFANO

  • Director
No longer subject to file 2018-03-23 0

BALLESTER ANDRE MICHEL CEO

  • Officer
No longer subject to file 2016-12-31 0

EQUINOX TWO S.C.A.

TOWER 6 S. A R.L.

  • 10% Owner
No longer subject to file 2016-09-21 0

GUTEDEL JACQUES PRESIDENT INTERCONTINENTAL

  • Officer
No longer subject to file 2016-08-09 0

DARNAUD MICHEL PRESIDENT CARDIAC SURGERY

  • Officer
No longer subject to file 2016-07-27 0

DI LULLO STEFANO PRES CARDIAC RHYTHM MGMT

  • Officer
No longer subject to file 2016-07-27 0

SHINMAR PRITPAL SR VP GLOBAL MARKET ACCESS

  • Officer
No longer subject to file 2016-07-27 0

VECCHI PIERO VP & CONTROLLER

  • Officer
No longer subject to file 2016-07-27 0

SHERIDAN BRIAN SR VP GENL COUNSEL & SECRETARY

  • Officer
0 2016-03-11 0

MAURO DEMETRIO CHIEF INTEGRATION OFFICER

  • Officer
No longer subject to file 2015-12-31 0

BIFULCO ROSARIO

  • Director
128,605 2015-10-19 0

HOARE ROHAN PRESIDENT, NEUROMODULATION

  • Officer
7,505 2015-10-19 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

MOORE DANIEL JEFFREY - Director

2019-08-19 S 1,500 $80.25 d 32,852 35,438.00 direct yes

HUSTON THAD ALLEN - Officer CHIEF FINANCIAL OFFICER

2019-08-12 S 2,000 $81.49 d 16,169 16,169.00 direct yes

MANKO DOUGLAS JOHN - Officer CHIEF ACCOUNTING OFFICER

2019-08-05 F 148 $77.00 d 2,352 2,352.00 direct

MANKO DOUGLAS JOHN - Officer CHIEF ACCOUNTING OFFICER

2019-08-05 M 605 a 2,500 2,352.00 direct

MANKO DOUGLAS JOHN - Officer CHIEF ACCOUNTING OFFICER

2019-08-05 M 605 d 8,306 2,352.00 direct

MOORE DANIEL JEFFREY - Director

2019-08-01 S 6,000 $80.00 d 34,352 36,938.00 direct yes

MCDONALD DAMIEN - Officer CEO

2019-08-01 S 1,000 $77.53 d 61,774 61,774.00 direct yes

MCDONALD DAMIEN - Officer CEO

2019-07-01 S 1,000 $72.60 d 62,774 62,774.00 direct yes

MANKO DOUGLAS JOHN - Officer CHIEF ACCOUNTING OFFICER

2019-06-28 A 159 $61.17 a 1,895 1,895.00 direct

SKEFFINGTON KEYNA PIDCOCK - Officer GENERAL COUNSEL

2019-06-28 J 15 $71.96 a 1,474 1,481.00 direct

ANDRLE EDWARD - Officer GENERAL MANAGER, NM

2019-06-28 A 273 $61.17 a 34,784 34,784.00 direct

SKEFFINGTON KEYNA PIDCOCK - Officer GENERAL COUNSEL

2019-06-28 J 7 a 1,481 1,481.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments